Magnetic resonance spectroscopy in very preterm-born children at 4 years of age: developmental course from birth and outcomes
Brain metabolites show very rapid maturation over infancy, particularly following very preterm (VPT) birth, and can provide an index of brain injury. The utility of magnetic resonance imaging (MRS, magnetic resonance spectroscopy) in predicting outcome in VPT-born infants is largely limited to 2-year outcomes. We examined the value of MRS in VPT followed longitudinally to 4 years.
MRS datasets were acquired in 45 VPT infants (< 32 weeks gestational age) longitudinally: at birth, at term-equivalent and at 4 years of age. Using LCModel analyses in a basal ganglia voxel, we investigated metabolite ratios as a function of age, brain injury and outcome. We also studied a full-term (FT) cohort at 4 years and compared group differences with outcome.
We found significant age-related changes in many brain metabolites in infancy, including phosphocreatine (CR)/phosphocholine (CHO), N-acetylaspartylglutamate (NAA)/CHO, myoinositol (INS)/CHO and INS/CR; there were no significant MRS differences between VPT and FT groups at 4 years of age, or differences at 4 years as a function of early brain injury or outcome. The rate of change in metabolite ratios from VPT birth to term-equivalent age did not predict outcome in the VPT children at 4 years.
Brain metabolite ratios measured in VPT-born infants have shown associations with short-term outcomes, but these correlations did not extend to early childhood nor predict cognitive sequelae. The most frequently reported poor outcome in VPT-born children is cognitive difficulties starting at early school age. MRS metrics early in the infant’s life do not appear to predict these longer-term outcomes.
KeywordsVery preterm born MRS Infants Children Outcome
We thank all of the families who gave their time over the years to participate in this study. We also thank Tammy Rayner and Ruth Weiss for their incredible skills and help with imaging young children, Dr. Hilary Whyte and Dr. Aideen Moore for all their clinical input and recruitment efforts and Ben Morgan, Wayne Lee and Enrica Manzato for their valuable support and contributions.
Compliance with ethical standards
This study was funded by the Canadian Institutes of Health Research (MOP #84399 and #137115).
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from the parents of all individual participants included in the study and informed assent from the children when they were 4 years of age.
- 6.Roelants-van Rijn AM, van der Grond J, Stigter RH, de Vries LS, Groenendaal F (2004) Cerebral structure and metabolism and long-term outcome in small-for-gestational-age preterm neonates. Pediatr Res 56(2):285–290. https://doi.org/10.1203/01.PDR.0000132751.09067.3F CrossRefPubMedGoogle Scholar
- 8.Cady EB, Penrice J, Amess PN, Lorek A, Wylezinska M, Aldridge RF, Franconi F, Wyatt JS, Reynolds EO (1996) Lactate, N-acetylaspartate, choline and creatine concentrations, and spin-spin relaxation in thalamic and occipito-parietal regions of developing human brain. Magn Reson Med 36(6):878–886CrossRefPubMedGoogle Scholar
- 9.Amess PN, Penrice J, Wylezinska M, Lorek A, Townsend J, Wyatt JS, Amiel-Tison C, Cady EB, Stewart A (1999) Early brain proton magnetic resonance spectroscopy and neonatal neurology related to neurodevelopmental outcome at 1 year in term infants after presumed hypoxic-ischaemic brain injury. Dev Med Child Neurol 41(7):436–445PubMedGoogle Scholar
- 13.Khong PL, Tse C, Wong IY, Lam BC, Cheung PT, Goh WH, Kwong NS, Ooi GC (2004) Diffusion-weighted imaging and proton magnetic resonance spectroscopy in perinatal hypoxic-ischemic encephalopathy: association with neuromotor outcome at 18 months of age. J Child Neurol 19(11):872–881. https://doi.org/10.1177/08830738040190110501 CrossRefPubMedGoogle Scholar
- 14.Zarifi MK, Astrakas LG, Poussaint TY, Plessis Ad A, Zurakowski D, Tzika AA (2002) Prediction of adverse outcome with cerebral lactate level and apparent diffusion coefficient in infants with perinatal asphyxia. Radiology 225(3):859–870. https://doi.org/10.1148/radiol.2253011797 CrossRefPubMedGoogle Scholar
- 15.Tanifuji S, Akasaka M, Kamei A, Araya N, Asami M, Matsumoto A, Sotodate G, Konishi Y, Shirasawa S, Toya Y, Kusano S, Chida S, Sasaki M, Matsuda T (2017) Temporal brain metabolite changes in preterm infants with normal development. Brain and Development 39(3):196–202. https://doi.org/10.1016/j.braindev.2016.10.006 CrossRefPubMedGoogle Scholar
- 17.Card D, Nossin-Manor R, Moore AM, Raybaud C, Sled JG, Taylor MJ (2013) Brain metabolite concentrations are associated with illness severity scores and white matter abnormalities in very preterm infants. Pediatr Res 74(1):75–81. https://doi.org/10.1038/pr.2013.62 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Wechsler D (2002) Wechsler preschool and primary scales of intelligence, 3rd edn. The Psychological Corporation, San AntonioGoogle Scholar
- 22.Semel E, Wiig E, Secord W (2004) Clinical evaluation of language fundamentals- ewPreschool, 2nd edn. The Psychological Corporation, San AntonioGoogle Scholar
- 23.Beery K, Buktenica N, Beery N (2010) Beery-Buktenica test of visual motor integration. San Antonio, TXGoogle Scholar
- 27.Wisnowski JL, Schmithorst VJ, Rosser T, Paquette L, Nelson MD, Haynes RL, Painter MJ, Bluml S, Panigrahy A (2014) Magnetic resonance spectroscopy markers of axons and astrogliosis in relation to specific features of white matter injury in preterm infants. Neuroradiology 56(9):771–779. https://doi.org/10.1007/s00234-014-1380-9 CrossRefPubMedGoogle Scholar
- 29.Koob M, Viola A, Le Fur Y, Ratiney H, Confort-Gouny S, Cozzone PJ, Giarard N (2016) Creatine, glutamine plus glutamate, and macromolecules are decreased in the central white matter of premature neonates around term. PLoS One 1(8):e0160990. https://doi.org/10.1371/journal.pone.0160990 CrossRefGoogle Scholar
- 30.Augustine EM, Spielman DM, Barnes PD, Sutcliffe TL, Dermon JD, Mirmiran M, Clayton DB, Ariagno RL (2008) Can magnetic resonance spectroscopy predict neurodevelopmental outcome in very low birth weight preterm infants? J Perinatol 28(9):611–618. https://doi.org/10.1038/jp.2008.66 CrossRefPubMedPubMedCentralGoogle Scholar
- 31.Van Kooij BJ, Benders MJ, Anbeek P, Van Haastert IC, De Vries LS, Groenendaal F (2012) Cerebellar volume and proton magnetic resonance spectroscopy at term, and neurodevelopment at 2 years of age in preterm infants. Dev Med Child Neurol 54(3):260–266. https://doi.org/10.1111/j.1469-8749.2011.04168.x CrossRefPubMedGoogle Scholar
- 34.Hyodo R, Sato Y, Ito M, Sugiyama Y, Ogawa C, Kawai H, Nakane T, Saito A, Hirakawa A, Kidokoro H, Natsume J, Hayakawa M (2017) Magnetic resonance spectroscopy in preterm infants: association with neurodevelopmental outcomes. Arch Dis Child Fetal Neonatal Ed. https://doi.org/10.1136/archdischild-2016-311403
- 35.Bapat R, Narayana PA, Zhou Y, Parikh NA (2014) Magnetic resonance spectroscopy at term-equivalent age in extremely preterm infants: association with cognitive and language development. Pediatr Neurol 51(1):53–59. https://doi.org/10.1016/j.pediatrneurol.2014.03.011 CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Kendall GS, Melbourne A, Johnson S, Price D, Bainbridge A, Gunny R, Huertas-Ceballos A, Cady EB, Ourselin S, Marlow N, Robertson NJ (2014) White matter NAA/CHO and CHO/CR ratios at MR spectroscopy are predictive of motor outcome in preterm infants. Radiology 271(1):230–238. https://doi.org/10.1148/radiol.13122679 CrossRefPubMedGoogle Scholar
- 37.Coker-Bolt P, Woodbury ML, Perkel J, Moreau NG, Hope K, Brown T, Ramakrishnan V, Mulvihill D, Jenkins D (2014) Identifying premature infants at high and low risk for motor delays using motor performance testing and MRS. J Pediatr Rehabil Med 7(3):219–232. https://doi.org/10.3233/PRM-140291 CrossRefPubMedGoogle Scholar
- 39.Akasaka M, Kamei A, Araya N, Matsumoto A, Konishi Y, Sotodate G, Shirasawa S, Toya Y, Kasai T, Chida S, Sasaki M (2016) Assessing temporal brain metabolite changes in preterm infants using multivoxel magnetic resonance spectroscopy. Magn Reson Med Sci 15(2):187–192. https://doi.org/10.2463/mrms.mp.2015-0041 CrossRefPubMedGoogle Scholar
- 40.Tomiyasu M, Aida N, Endo M, Shibasaki J, Nozawa K, Shimizu E, Tsuji H, Obata T (2013) Neonatal brain metabolite concentrations: an in vivo magnetic resonance spectroscopy study with a clinical MR system at 3 Tesla. PLoS One 8(11):e82746. https://doi.org/10.1371/journal.pone.0082746 CrossRefPubMedPubMedCentralGoogle Scholar
- 47.Sellier E, Platt MJ, Andersen GL, Krageloh-Mann I, De La Cruz J, Cans C, Surveillance of Cerebral Palsy N (2016) Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Dev Med Child Neurol 58(1):85–92. https://doi.org/10.1111/dmcn.12865 CrossRefPubMedGoogle Scholar